Evogene Priced, NYSE: EVGN
Develops genetically enhanced seeds to elevate crop performance and productivity.
Industry: Health Care
First Day Return: +16.8%
Industry: Health Care
EVGN
Develops genetically enhanced seeds to elevate crop performance and productivity.
| IPO Data | |
|---|---|
| IPO File Date | 09/23/2013 |
| Offer Price | $14.75 |
| Price Range $17.16 - $17.16 | |
| Offer Shares (mm) | 5.0 |
| Deal Size ($mm) | $74 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 11/20/2013 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $74 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Rehovot, Israel |
| Founded | 2000 |
| Employees at IPO | 188 |
| Website www.evogene.com | |
IPO News for Evogene
Evogene (EVGN) Performance
